Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'difluorodeoxycytidine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 219 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Doyle, TH; Mornex, F; McKenna, G
      The clinical implications of gemcitabine radiosensitization

      CLINICAL CANCER RESEARCH
    2. Blackstock, AW; Lightfoot, H; Case, LD; Tepper, JE; Mukherji, SK; Mitchell, BS; Swarts, SG; Hess, SM
      Tumor uptake and elimination of 2 ',2 '-difluoro-2 '-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: Correlation with in vivo tumor response

      CLINICAL CANCER RESEARCH
    3. McGinn, CJ; Lawrence, TS
      Recent advances in the use of radio sensitizing nucleosides

      SEMINARS IN RADIATION ONCOLOGY
    4. Hansen, SW
      Gemcitabine in the treatment of ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    5. Nabhan, C; Krett, N; Gandhi, V; Rosen, S
      Gemcitabine in hematologic malignancies

      CURRENT OPINION IN ONCOLOGY
    6. Smid, K; Van Moorsel, CJA; Noordhuis, P; Voorn, DA; Peters, GJ
      Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Beausejour, CM; Eliopoulos, N; Momparler, L; Le, NLO; Momparler, RL
      Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene

      CANCER GENE THERAPY
    8. Miura, S; Yoshimura, Y; Satoh, H; Izuta, S
      The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: Effects of its triphosphate on mammalian DNA polymerases

      JAPANESE JOURNAL OF CANCER RESEARCH
    9. Matsumoto, M; Takeda, Y; Maki, H; Hojo, K; Wada, T; Nishitani, Y; Maekawa, R; Yoshioka, T
      Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    10. Eisbruch, A; Shewach, DS; Bradford, CR; Littles, JF; Teknos, TN; Chepeha, DB; Marentette, LJ; Terrell, JE; Hogikyan, ND; Dawson, LA; Urba, S; Wolf, GT; Lawrence, TS
      Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study

      JOURNAL OF CLINICAL ONCOLOGY
    11. Patel, SR; Gandhi, V; Jenkins, J; Papadopolous, N; Burgess, MA; Plager, C; Plunkett , W; Benjamin, RS
      Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation

      JOURNAL OF CLINICAL ONCOLOGY
    12. Casali, M; Marcellini, M; Casali, A; Giuntini, T; Galante, E; Ferrone, C
      Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    13. Okada, S; Ueno, H; Okusaka, T; Ikeda, M; Furuse, J; Maru, Y
      Phase I trial of gemcitabine in patients with advanced pancreatic cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    14. Blackstock, AW; Lesser, GJ; Fletcher-Steede, J; Case, LD; Tucker, RW; Russo, SM; White, DR; Miller, A
      Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    15. Yavuz, AA; Aydin, F; Yavuz, MN; Ilis, E; Ozdemir, F
      Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine advanced pancreatic cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    16. Guo, PG; Ma, JG; Li, SL; Guo, ZW; Adams, AL; Gallo, JM
      Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    17. Haberkorn, U; Bellemann, ME; Brix, G; Kamencic, H; Morr, I; Traut, U; Altmann, A; Doll, J; Blatter, J; Kinscherf, R
      Apoptosis and changes in glucose transport early after treatment of Morrishepatoma with gemcitabine

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    18. Cividalli, A; Livdi, E; Ceciarelli, F; Fontana, G; Altavista, P; Cruciani, G; Danesi, DT
      Combined use of gemcitabine and radiation in mice

      ANTICANCER RESEARCH
    19. Huisman, C; Giaccone, G; van Groeningen, CJ; Sutedja, G; Postmus, PE; Smit, EF
      Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling

      LUNG CANCER
    20. Samlowski, WE; Gundacker, H; Kuebler, JP; Giguere, JK; Mills, GM; Schuller, DE; Ensley, JF
      Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study

      INVESTIGATIONAL NEW DRUGS
    21. Seidman, AD
      The evolving role of gemcitabine in the management of breast cancer

      ONCOLOGY
    22. Cappella, P; Tomasoni, D; Faretta, M; Lupi, M; Montalenti, F; Viale, F; Banzato, F; D'Incalci, M; Ubezio, P
      Cell cycle effects of gemcitabine

      INTERNATIONAL JOURNAL OF CANCER
    23. Rodicker, F; Stiewe, T; Zimmermann, S; Putzer, BM
      Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction

      CANCER RESEARCH
    24. Gourdeau, H; Clarke, ML; Ouellet, F; Mowles, D; Selner, M; Richard, A; Lee, N; Mackey, JR; Young, JD; Jolivet, J; Lafreniere, RG; Cass, CE
      Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines

      CANCER RESEARCH
    25. Sun, WJ; Stevenson, JP; Gallagher, M; Giantonio, B; Algazy, K; Haller, D; Vaughn, D; Raskay, BJ; O'Dwyer, PJ
      A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors

      CANCER
    26. Millikan, RE; Plunkett, WK; Smith, TL; Williams, DL; Logothetis, CJ
      Gemcitabine modulation of alkylator therapy - A Phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin

      CANCER
    27. Bandala, E; Espinosa, M; Maldonado, V; Melendez-Zajgla, J
      Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine

      BIOCHEMICAL PHARMACOLOGY
    28. Azuma, A; Huang, P; Matsuda, A; Plunkett, W
      Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)

      BIOCHEMICAL PHARMACOLOGY
    29. Bergman, AM; Munch-Petersen, B; Jensen, PB; Sehested, M; Veerman, G; Voorn, DA; Smid, K; Pinedo, HM; Peters, GJ
      Collateral sensitivity to gemcitabine (2 ',2 ' -difluorodeoxycytidine) andcytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines

      BIOCHEMICAL PHARMACOLOGY
    30. Yang, LY; Li, L; Jiang, H; Shen, Y; Plunkett, W
      Expression of ERCC1 antisense RNA abrogates gemcitabine-mediated cytotoxicsynergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair

      CLINICAL CANCER RESEARCH
    31. Brodowicz, T; Kostler, WJ; Moslinger, R; Tomek, S; Vaclavik, I; Herscovici, V; Wiltschke, C; Steger, GG; Wein, W; Seifert, M; Kubista, E; Zielinski, CC
      Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer

      BREAST
    32. van Moorsel, CJA; Pinedo, HM; Smid, K; Comijn, EM; Voorn, DA; Veerman, G; Lakerveld, B; Van der Vijgh, WJF; Giaccone, G; Postmus, PE; Peters, GJ
      Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin inmice bearing Lewis lung murine non-small cell lung tumours

      EUROPEAN JOURNAL OF CANCER
    33. Brodowicz, T; Wolfram, RM; Kostler, WJ; Tomek, S; Vaclavik, I; Steger, GG; Teleky, B; Fugger, R; Jakesz, R; Zielinski, CC
      Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer

      ANTI-CANCER DRUGS
    34. Chow, KU; Ries, J; Weidmann, E; Pourebrahim, F; Napieralski, S; Stieler, M; Boehrer, S; Rummel, MJ; Stein, J; Hoelzer, D; Mitrou, PS
      Induction of apoptosis using 2 ',2 ' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphaticand myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

      ANNALS OF HEMATOLOGY
    35. Pignata, S; Varriale, E; Casella, G; Iodice, F; De Placido, G; Perrone, F; Tramontana, F; Ricchi, P; De Vivo, R; Costanzo, R; Vernaglia, A; Tramontana, S
      A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer

      ANNALS OF ONCOLOGY
    36. Delord, JP; Raymond, E; Chaouche, M; Ruffie, P; Ducreux, M; Faivre, S; Boige, V; Le Chevalier, T; Rixe, O; Baudin, E; Pautier, P; Rodier, JM; Chouaki, N; Escudier, B; Kayitalire, L; Armand, JP
      A dose-finding study of gemcitabine and vinorelbine in advanced previouslytreated malignancies

      ANNALS OF ONCOLOGY
    37. Kornmann, M; Butzer, U; Blatter, J; Beger, HG; Link, KH
      Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    38. Venook, AP; Egorin, MJ; Rosner, GL; Hollis, D; Mani, S; Hawkins, M; Byrd, J; Hohl, R; Budman, D; Meropol, NJ; Ratain, MJ
      Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565

      JOURNAL OF CLINICAL ONCOLOGY
    39. Santoro, A; Bredenfeld, H; Devizzi, L; Tesch, H; Bonfante, V; Viviani, S; Fielder, F; Parra, HS; Benoehr, C; Pacini, M; Bonadonna, G; Diehl, V
      Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study

      JOURNAL OF CLINICAL ONCOLOGY
    40. Nagourney, RA; Link, JS; Blitzer, JB; Forsthoff, C; Evans, SS
      Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    41. Lech-Maranda, E; Korycka, A; Robak, T
      The interaction of gemcitabine and cytarabine on murine leukemias L1210 orP388 and on human normal and leukemic cell growth in vitro

      HAEMATOLOGICA
    42. Moog, R; Brandl, M; Schubert, R; Unger, C; Massing, U
      Effect of nucleoside analogues and oligonucleotides on hydrolysis of liposomal phospholipids

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    43. Fields, MT; Eisbruch, A; Normolle, D; Orfall, A; Davis, MA; Pu, AT; Lawrence, TS
      Radiosensitization produced in vivo by once- vs. twice-weekly 2 ' 2 '-difluoro-2 '-deoxycytidine (gemcitabine)

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    44. Jiang, HY; Hickey, RJ; Abdel-Aziz, W; Malkas, LH
      Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    45. Aung, TT; Davis, MA; Ensminger, WD; Lawrence, TS
      Interaction between gemcitabine and mitomycin-C in vitro

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    46. van Moorsel, CJA; Bergman, AM; Veerman, G; Voorn, DA; van Haperen, VWTR; Kroep, JR; Pinedo, HM; Peters, GJ
      Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    47. Muenchen, HJ; Quigley, MM; Pilat, MJP; Lehr, JE; Brumfield, SK; Mahoney, M; Pienta, KJ
      The study of gemcitabine in combination with other chemotherapeutic agentsas an effective treatment for prostate cancer

      ANTICANCER RESEARCH
    48. Cividalli, A; Mauro, F; Livdi, E; Ceciarelli, F; Altavista, P; Cruciani, G; Danesi, DT
      Schedule dependent toxicity and efficacy of combined gemcitabine/paclitaxel treatment in mouse adenocarcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    49. Sculier, JP; Lafitte, JJ; Berghmans, T; Thiriaux, J; Lecomte, J; Efremidis, A; Ninane, V; Paesmans, M; Mommen, P; Klastersky, J
      A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

      LUNG CANCER
    50. Manegold, C; Zatloukal, P; Krejcy, K; Blatter, J
      Gemcitabine in non-small cell lung cancer (NSCLC)

      INVESTIGATIONAL NEW DRUGS
    51. Mavroudis, D; Kourousis, C; Kakolyris, S; Agelaki, S; Kalbakis, K; Androulakis, N; Souglakos, J; Vardakis, N; Samonis, G; Georgoulias, V
      Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report

      SEMINARS IN ONCOLOGY
    52. Feliu, J; Alvarez, MPL; Jaraiz, MA; Constenla, M; Vicent, JM; Belon, J; Gomez, LL; de Castro, J; Dorta, J; Baron, MG
      Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma

      CANCER
    53. Yang, TS; Lin, YC; Chen, JS; Wang, HM; Wang, CH
      Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

      CANCER
    54. Ryan, DP; Lynch, TJ; Grossbard, ML; Seiden, MV; Fuchs, CS; Grenon, N; Baccala, P; Berg, D; Finkelstein, D; Mayer, RJ; Clark, JW
      A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

      CANCER
    55. Kroep, JR; Giaccone, G; Tolis, C; Voorn, DA; Loves, WJP; van Groeningen, CJ; Pinedo, HM; Peters, GJ
      Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small cell lung cancer cell lines

      BRITISH JOURNAL OF CANCER
    56. Zhu, CY; Johansson, M; Karlsson, A
      The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    57. Crenshaw, TR; Cory, JG
      Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazoneshow altered response to DNA damaging agents

      INTERNATIONAL JOURNAL OF ONCOLOGY
    58. van Moorsel, CJA; Pinedo, HM; Veerman, G; Vermorken, JB; Postmus, PE; Peters, GJ
      Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing mice

      EUROPEAN JOURNAL OF CANCER
    59. Padron, JM; van Moorsel, CJA; Bergman, AM; Smitskamp-Wilms, E; van der Wilt, CL; Peters, GJ
      Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures

      ANTI-CANCER DRUGS
    60. Weinmann, M; Brandes, A; Classen, J; Schott, U; Bamberg, M
      Impressive remission in a patient with locally advanced malignant pleural mesothelioma treated with gemcitabine

      ANTI-CANCER DRUGS
    61. Rosier, JF; Beauduin, M; Bruniaux, M; De Bast, M; De Coster, B; Octave-Prignot, M; Scalliet, P; Gregoire, V
      The effect of 2 '-2 ' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    62. van Moorsel, CJA; Kroep, JR; Pinedo, HM; Veerman, G; Voorn, DA; Postmus, PE; Vermorken, JB; van Groeningen, CJ; van der Vijgh, WJF; Peters, GJ
      Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors

      ANNALS OF ONCOLOGY
    63. Kelly, K
      The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    64. Hansen, SW; Tuxen, MK; Sessa, C
      Gemcitabine in the treatment of ovarian cancer

      ANNALS OF ONCOLOGY
    65. Lawrence, TS; Eisbruch, A; McGinn, CJ; Fields, MT; Shewach, DS
      Radiosensitization by gemcitabine

      ONCOLOGY-NEW YORK
    66. Kroep, JR; Giaccone, G; Voorn, DA; Smit, EF; Beijnen, JH; Rosing, H; van Moorsel, CJA; van Groeningen, CJ; Postmus, PE; Pinedo, HM; Peters, GJ
      Gemcitabine and paclitaxel: Pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    67. Blackstock, AW; Bernard, SA; Richards, F; Eagle, KS; Case, LD; Poole, ME; Savage, PD; Tepper, JE
      Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

      JOURNAL OF CLINICAL ONCOLOGY
    68. Fossa, A; Santoro, A; Hiddemann, W; Truemper, L; Niederle, N; Buksmaui, S; Bonadonna, G; Seeber, S; Nowrousian, MR
      Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    69. Mason, KA; Milas, L; Hunter, NR; Elshaikh, M; Buchmiller, L; Kishi, K; Hittelman, KW; Ang, KK
      Maximizing therapeutic gain with gemcitabine and fractionated radiation

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    70. Miura, S; Yoshimura, Y; Endo, M; Satoh, H; Machida, H; Sasaki, T
      Comparison of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity

      CANCER LETTERS
    71. Pacini, S; Milano, F; Pinzani, P; Pazzagli, M; Gulisano, M; Ruggiero, M; Casamassima, F
      Effects of gemcitabine in normal and transformed human lung cell cultures:Cytotoxicity and increase in radiation sensitivity

      TUMORI
    72. Silver, DF; Piver, MS
      Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneum

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    73. Van Bree, C; Beumer, C; Rodermond, HM; Haveman, J; Bakker, PJM
      Effectiveness of 2 ',2 ' difluorodeoxycytidine (Gemcitabine) combined withhyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    74. Bahadori, HR; Lima, CMSR; Green, MR; Safa, AR
      Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines

      ANTICANCER RESEARCH
    75. Sauer-Heilborn, A; Kath, R; Schneider, CP; Hoffken, K
      Severe non-haematological toxicity after treatment with gemcitabine

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    76. Poplin, E; Roberts, J; Tombs, M; Grant, S; Rubin, E
      Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study

      INVESTIGATIONAL NEW DRUGS
    77. Stucky-Marshall, L
      New agents in gastrointestinal malignancies: Part 2. Gemcitabine in clinical practice

      CANCER NURSING
    78. Hammond, JR; Lee, S; Ferguson, PJ
      [H-3]gemcitabine uptake by nucleoside transporters in a human head and neck squamous carcinoma cell line

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    79. Rieger, J; Durka, S; Streffer, J; Dichgans, J; Weller, M
      Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone

      EUROPEAN JOURNAL OF PHARMACOLOGY
    80. Coucke, PA; Decosterd, LA; Li, YX; Cottin, E; Chen, XG; Sun, LQ; Stern, S; Paschoud, N; Denekamp, J
      The ribonucleoside diphosphate reductase inhibitor (E)-2 '-deoxy(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro

      CANCER RESEARCH
    81. Goan, YG; Zhou, BS; Hu, E; Mi, S; Yen, Y
      Overexpression of ribonucleotide reductase as a mechanism of resistance to2,2-difluorodeoxycytidine in the human KB cancer cell line

      CANCER RESEARCH
    82. Tonkinson, JL; Worzalla, JF; Teng, CH; Mendelsohn, LG
      Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma

      CANCER RESEARCH
    83. van Moorsel, CJA; Pinedo, HM; Veerman, G; Bergman, AM; Kuiper, CM; Vermorken, JB; van der Vijgh, WJF; Peters, GJ
      Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

      BRITISH JOURNAL OF CANCER
    84. Di Stefano, G; Busi, C; Mattioli, A; Derenzini, M; Trere, D; Fiume, L
      Inhibition of [H-3]thymidine incorporation into DNA of rat regenerating liver by 2 ',2 '-difluorodeoxycytidine coupled to lactosaminated poly-L-lysine

      BIOCHEMICAL PHARMACOLOGY
    85. van Moorsel, CJA; Pinedo, HM; Veerman, G; Guechev, A; Smid, K; Loves, WJP; Vermorken, JB; Postmus, PE; Peters, GJ
      Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines

      BIOCHEMICAL PHARMACOLOGY
    86. Mackey, JR; Yao, SYM; Smith, KM; Karpinski, E; Baldwin, SA; Cass, CE; Young, JD
      Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    87. MACKEY JR; BALDWIN SA; YOUNG JD; CASS CE
      NUCLEOSIDE TRANSPORT AND ITS SIGNIFICANCE FOR ANTICANCER DRUG-RESISTANCE

      DRUG RESISTANCE UPDATES
    88. MIWA M; EDA H; URA M; OUCHI KF; KEITH DD; FOLEY LH; ISHITSUKA H
      HIGH SUSCEPTIBILITY OF HUMAN CANCER XENOGRAFTS WITH HIGHER LEVELS OF CYTIDINE DEAMINASE TO A 2'-DEOXYCYTIDINE ANTIMETABOLITE, 2'-DEOXY-2'-METHYLIDENECYTIDINE

      Clinical cancer research
    89. MIWA M; EDA H; URA M; OUCHI KF; KEITH DD; FOLEY LH; ISHITSUKA H
      HIGH SUSCEPTIBILITY OF HUMAN CANCER XENOGRAFTS WITH HIGHER LEVELS OF CYTIDINE DEAMINASE TO A 2'-DEOXYCYTIDINE ANTIMETABOLITE, 2'-DEOXY-2'-METHYLIDENECYTIDINE

      Clinical cancer research
    90. REN QF; KAO V; GREM JL
      CYTOTOXICITY AND DNA FRAGMENTATION ASSOCIATED WITH SEQUENTIAL GEMCITABINE AND 5-FLUORO-2'-DEOXYURIDINE IN HT-29 COLON-CANCER CELLS

      Clinical cancer research
    91. ROHDE D; THIEMANN D; WILDBERGER J; WOLFF J; JAKSE G
      TREATMENT OF RENAL-CANCER PATIENTS WITH GEMCITABINE (2',2'-DIFLUORODEOXYCYTIDINE) AND INTERFERONS - ANTITUMOR-ACTIVITY AND TOXICITY

      Oncology Reports
    92. ROHDE D; HAYN HK; BLATTER J; JAKSE G
      THE EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) COMBINED WITH INTERFERON IN HUMAN RENAL-CELL CARCINOMA CELL-LINES

      International journal of oncology
    93. ROHDE D; GOERTZ M; BLATTER J; JAKSE G
      THE EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AND VINBLASTINE COMBINED WITH INTERFERON IN NUDE-MICE XENOGRAFTS OF HUMAN RENAL-CELL CARCINOMA

      International journal of oncology
    94. THEODOSSIOU C; COOK JA; FISHER J; TEAGUE D; LIEBMANN JE; RUSSO A; MITCHELL JB
      INTERACTION OF GEMCITABINE WITH PACLITAXEL AND CISPLATIN IN HUMAN TUMOR-CELL LINES

      International journal of oncology
    95. LORUSSO V; POLLERA CF; ANTIMI M; LUPORINI G; GRIDELLI C; FRASSINETI GL; OLIVA C; PACINI M; DELENA M
      A PHASE-II STUDY OF GEMCITABINE IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT PREVIOUSLY TREATED WITH PLATINUM

      European journal of cancer
    96. SMITSKAMPWILMS E; PINEDO HM; VEERMAN G; VANHAPEREN VWTR; PETERS GJ
      POSTCONFLUENT MULTILAYERED CELL-LINE CULTURES FOR SELECTIVE SCREENINGOF GEMCITABINE

      European journal of cancer
    97. KANAZAWA J; TAKAHASHI T; AKINAGA S; TAMAOKI T; OKABE M
      THE RELATIONSHIP BETWEEN THE ANTITUMOR-ACTIVITY AND THE RIBONUCLEOTIDE REDUCTASE INHIBITORY ACTIVITY OF (E)-2'-DEOXY-2'-(FLUOROMETHYLENE) CYTIDINE, MDL 101,731

      Anti-cancer drugs
    98. GREGOIRE V; BEAUDUIN M; BRUNIAUX M; DECOSTER B; PRIGNOT MO; SCALLIET P
      RADIOSENSITIZATION OF MOUSE SARCOMA-CELLS BY FLUDARABINE (F-ARA-A) ORGEMCITABINE (DFDC), 2 NUCLEOSIDE ANALOGS, IS NOT MEDIATED BY AN INCREASED INDUCTION OR A REPAIR INHIBITION OF DNA DOUBLE-STRAND BREAKS AS MEASURED BY PULSED-FIELD GEL-ELECTROPHORESIS

      International journal of radiation biology
    99. TOUROUTOGLOU N; GRAVEL D; RABER MN; PLUNKETT W; ABBRUZZESE JL
      CLINICAL-RESULTS OF A PHARMACODYNAMICALLY-BASED STRATEGY FOR HIGHER DOSING OF GEMCITABINE IN PATIENTS WITH SOLID TUMORS

      Annals of oncology
    100. Thomas, A; Steward, WP
      Gemcitabine - a major advance?

      ANNALS OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 11:55:30